Results 1 to 10 of about 56,610 (283)

Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. [PDF]

PLoS Biology, 2018
The oral polio vaccine (OPV) contains live-attenuated polioviruses that induce immunity by causing low virulence infections in vaccine recipients and their close contacts. Widespread immunization with OPV has reduced the annual global burden of paralytic
Michael Famulare, Christian Selinger, Kevin A McCarthy, Philip A Eckhoff, Guillaume Chabot-Couture   +4 more
doaj   +10 more sources

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence. [PDF]

Front Immunol, 2022
Background Effective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could ...
Yagovkina NV, Zheleznov LM, Subbotina KA, Tsaan AA, Kozlovskaya LI, Gordeychuk IV, Korduban AK, Ivin YY, Kovpak AA, Piniaeva AN, Shishova AA, Shustova EY, Khapchaev YK, Karganova GG, Siniugina AA, Pomaskina TV, Erovichenkov AA, Chumakov K, Ishmukhametov AA.   +18 more
europepmc   +5 more sources

Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies? [PDF]

Open Forum Infect Dis, 2021
The global coronavirus disease 2019 pandemic has raised significant concerns of developing rapid, broad strategies to protect the vulnerable population and prevent morbidity and mortality.
Malave Sanchez M, Saleeb P, Kottilil S, Mathur P.   +3 more
europepmc   +3 more sources

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception [PDF]

Human Vaccines & Immunotherapeutics, 2022
Although safe, rotavirus vaccines have been associated with increased intussusception risk. In Brazil, after the oral human rotavirus vaccine (OHRV) introduction in the childhood immunization, in 2006, increased intussusception risk was identified after ...
Camila Cristina Martini Rodrigues, Eder Gatti Fernandes, Paulo Piva dos Santos, Renato Yoshio Eguti, Antonio Carlos Pedroso-de-Lima, Gisela Tunes da Silva, Ana Marli Christovam Sartori   +6 more
doaj   +4 more sources

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region. [PDF]

J Infect Dis, 2017
The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus–containing vaccine and introduction of inactivated polio vaccine in routine immunization to mitigate against risk ...
Tevi-Benissan C, Okeibunor J, du Châtellier GM, Assefa A, Biey JN, Cheikh D, Eshetu M, Anya BP, Dao H, Nasir Y, Akanmori BD, Mihigo R.   +11 more
europepmc   +5 more sources

Use of oral polio vaccine and the incidence of COVID-19 in the world. [PDF]

PLoS One, 2022
Background Several live attenuated vaccines were shown to provide temporary protection against a variety of infectious diseases through stimulation of the host innate immune system. Objective To test the hypothesis that countries using oral polio vaccine
Habibzadeh F, Chumakov K, Sajadi MM, Yadollahie M, Stafford K, Simi A, Kottilil S, Hafizi-Rastani I, Gallo RC.   +8 more
europepmc   +2 more sources

One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19. [PDF]

Front Public Health, 2022
Introduction Recent reviews summarize evidence that some vaccines have heterologous or non-specific effects (NSE), potentially offering protection against multiple pathogens.
Chang AY, Aaby P, Avidan MS, Benn CS, Bertozzi SM, Blatt L, Chumakov K, Khader SA, Kottilil S, Nekkar M, Netea MG, Sparrow A, Jamison DT.   +12 more
europepmc   +2 more sources

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. [PDF]

Euro Surveill, 2022
We report an emergence and increase in poliovirus type 2 detection via routine wastewater surveillance in three non-overlapping regions in the Jerusalem region, Israel, between April and July 2022.
Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, Levi N, Weiss L, Aguvaev I, Cohen Z, Kestin K, Vasserman R, Elul M, Fratty IS, Geva M, Wax M, Erster O, Yishai R, Hecht-Sagie L, Alroy-Preis S, Mendelson E, Weil M.   +21 more
europepmc   +2 more sources

Albert Bruce Sabin: The Man Who Made the Oral Polio Vaccine [PDF]

Emerg Infect Dis, 2022
The article features Albert Bruce Sabin (1906-1993), who is credited as the developer of the oral polio vaccine (OPV) for the treatment of poliomyelitis. Also cited are the influence of William Hallock Park as mentor of Sabin, as well as how Sabin's work
D. Orsini, M. Martini
europepmc   +2 more sources

Oral polio vaccine stockpile modeling: insights from recent experience

Expert Review of Vaccines, 2023
Background Achieving polio eradication requires ensuring the delivery of sufficient supplies of the right vaccines to the right places at the right times.
Kimberly M. Thompson, Dominika A. Kalkowska, Kamran Badizadegan   +2 more
doaj   +2 more sources